167 related articles for article (PubMed ID: 31397806)
21. Multiple roles for the major histocompatibility complex class I- related receptor FcRn.
Ghetie V; Ward ES
Annu Rev Immunol; 2000; 18():739-66. PubMed ID: 10837074
[TBL] [Abstract][Full Text] [Related]
22. Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life.
Mackness BC; Jaworski JA; Boudanova E; Park A; Valente D; Mauriac C; Pasquier O; Schmidt T; Kabiri M; Kandira A; Radošević K; Qiu H
MAbs; 2019 Oct; 11(7):1276-1288. PubMed ID: 31216930
[TBL] [Abstract][Full Text] [Related]
23. New functions of the MHC class I-related Fc receptor, FcRn.
Simister NE; Jacobowitz Israel E; Ahouse JC; Story CM
Biochem Soc Trans; 1997 May; 25(2):481-6. PubMed ID: 9191140
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(,).
West AP; Bjorkman PJ
Biochemistry; 2000 Aug; 39(32):9698-708. PubMed ID: 10933786
[TBL] [Abstract][Full Text] [Related]
25. [Neonatal Fc receptor (FcRn)-A Novel Therapeutic Approach for Autoimmune Disease].
Murai H; Harada D
Brain Nerve; 2024 Feb; 76(2):183-191. PubMed ID: 38351566
[TBL] [Abstract][Full Text] [Related]
26. Selection of bispecific antibodies with optimal developability using FcRn‑Ph‑HPLC as an optimized FcRn affinity chromatography method.
Müller T; Tasser C; Tesar M; Fucek I; Schniegler-Mattox U; Koch J; Ellwanger K
MAbs; 2023; 15(1):2245519. PubMed ID: 37599441
[TBL] [Abstract][Full Text] [Related]
27. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration.
Smith B; Kiessling A; Lledo-Garcia R; Dixon KL; Christodoulou L; Catley MC; Atherfold P; D'Hooghe LE; Finney H; Greenslade K; Hailu H; Kevorkian L; Lightwood D; Meier C; Munro R; Qureshi O; Sarkar K; Shaw SP; Tewari R; Turner A; Tyson K; West S; Shaw S; Brennan FR
MAbs; 2018 Oct; 10(7):1111-1130. PubMed ID: 30130439
[TBL] [Abstract][Full Text] [Related]
28. Associations between an IgG3 polymorphism in the binding domain for FcRn, transplacental transfer of malaria-specific IgG3, and protection against Plasmodium falciparum malaria during infancy: A birth cohort study in Benin.
Dechavanne C; Dechavanne S; Sadissou I; Lokossou AG; Alvarado F; Dambrun M; Moutairou K; Courtin D; Nuel G; Garcia A; Migot-Nabias F; King CL
PLoS Med; 2017 Oct; 14(10):e1002403. PubMed ID: 28991911
[TBL] [Abstract][Full Text] [Related]
29. Antagonism of the Neonatal Fc Receptor as an Emerging Treatment for Myasthenia Gravis.
Gable KL; Guptill JT
Front Immunol; 2019; 10():3052. PubMed ID: 31998320
[TBL] [Abstract][Full Text] [Related]
30. Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge.
Stapleton NM; Brinkhaus M; Armour KL; Bentlage AEH; de Taeye SW; Temming AR; Mok JY; Brasser G; Maas M; van Esch WJE; Clark MR; Williamson LM; van der Schoot CE; Vidarsson G
Sci Rep; 2019 May; 9(1):7363. PubMed ID: 31089170
[TBL] [Abstract][Full Text] [Related]
31. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases.
Li N; Zhao M; Hilario-Vargas J; Prisayanh P; Warren S; Diaz LA; Roopenian DC; Liu Z
J Clin Invest; 2005 Dec; 115(12):3440-50. PubMed ID: 16284651
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the interactions of rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG isotypes.
Szikora B; Hiripi L; Bender B; Kacskovics I; Iliás A
PLoS One; 2017; 12(9):e0185662. PubMed ID: 28957416
[TBL] [Abstract][Full Text] [Related]
33. Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics.
Piche-Nicholas NM; Avery LB; King AC; Kavosi M; Wang M; O'Hara DM; Tchistiakova L; Katragadda M
MAbs; 2018 Jan; 10(1):81-94. PubMed ID: 28991504
[TBL] [Abstract][Full Text] [Related]
34. The multiple facets of FcRn in immunity.
Stapleton NM; Einarsdóttir HK; Stemerding AM; Vidarsson G
Immunol Rev; 2015 Nov; 268(1):253-68. PubMed ID: 26497526
[TBL] [Abstract][Full Text] [Related]
35. NF-kappaB signaling regulates functional expression of the MHC class I-related neonatal Fc receptor for IgG via intronic binding sequences.
Liu X; Ye L; Christianson GJ; Yang JQ; Roopenian DC; Zhu X
J Immunol; 2007 Sep; 179(5):2999-3011. PubMed ID: 17709515
[TBL] [Abstract][Full Text] [Related]
36. Blocking Placental Class G Immunoglobulin Transfer Prevents NMDA Receptor Antibody Effects in Newborn Mice.
García-Serra A; Radosevic M; Ríos J; Aguilar E; Maudes E; Landa J; Sabater L; Martinez-Hernandez E; Planagumà J; Dalmau J
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34580181
[TBL] [Abstract][Full Text] [Related]
37. Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer.
Porter C; Armstrong-Fisher S; Kopotsha T; Smith B; Baker T; Kevorkian L; Nesbitt A
J Reprod Immunol; 2016 Aug; 116():7-12. PubMed ID: 27123565
[TBL] [Abstract][Full Text] [Related]
38. Methods for Functional Characterization of FcRn Interactions with Therapeutic Antibodies and Fc-Fusion Proteins.
Chung S; Lin YL; Nguyen V; Liu C
Methods Mol Biol; 2022; 2313():295-303. PubMed ID: 34478146
[TBL] [Abstract][Full Text] [Related]
39. The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.
Sesarman A; Vidarsson G; Sitaru C
Cell Mol Life Sci; 2010 Aug; 67(15):2533-50. PubMed ID: 20217455
[TBL] [Abstract][Full Text] [Related]
40. In vivo depletion of serum IgG by an affibody molecule binding the neonatal Fc receptor.
Seijsing J; Yu S; Frejd FY; Höiden-Guthenberg I; Gräslund T
Sci Rep; 2018 Mar; 8(1):5141. PubMed ID: 29572538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
